Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Cartesian Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 6
Estimación de BPA
$-0.700
Estimación de ingresos trimestrales
$226.54K
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$1.03M
Analice el historial de beneficios de Cartesian Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics | -$1.13 | -$0.70 | — | — | $387.00K | $226.54K | — | — | 11/06/2025 | |
RNAC | Cartesian Therapeutics | $0.54 | -$0.69 | $0.50 | 172.46% | $33.45M | $787.50K | $298.00K | -62.16% | 08/07/2025 | |
RNAC | Cartesian Therapeutics | -$10.50 | -$0.61 | -$0.68 | -11.48% | $5.84M | $500.00K | $1.10M | 120.00% | 05/08/2025 | |
RNAC | Cartesian Therapeutics | -$41.70 | -$0.83 | -$0.40 | 51.81% | $8.27M | $100.00K | -$759.00K | -859.00% | 03/13/2025 | |
RNAC | Cartesian Therapeutics | -$1.80 | -$0.73 | -$1.13 | -54.79% | $6.55M | $2.54M | $387.00K | -84.76% | 11/07/2024 | |
RNAC | Cartesian Therapeutics | -$0.07 | -$1.19 | $0.54 | 145.38% | $5.25M | $1.83M | $33.45M | 1727.60% | 08/08/2024 | |
RNAC | Cartesian Therapeutics | -$4.24 | -$0.88 | -$10.50 | -1093.18% | $5.94M | $1.25M | $5.84M | 367.20% | 05/08/2024 | |
RNAC | Cartesian Therapeutics | $0.04 | -$0.90 | -$41.70 | -4533.33% | $16.80M | $5.87M | $8.27M | 40.82% | 03/07/2024 | |
RNAC | Cartesian Therapeutics | -$0.05 | -$1.80 | -$1.80 | 0.00% | $20.71M | $11.02M | $6.55M | -40.55% | 11/13/2023 | |
RNAC | Cartesian Therapeutics | $0.06 | -$0.08 | -$0.07 | 12.50% | $39.27M | $11.09M | $5.25M | -52.67% | 08/17/2023 | |
RNAC | Cartesian Therapeutics | $0.08 | -$0.09 | -$0.14 | -55.56% | $34.00M | $11.83M | $5.94M | -49.81% | 05/04/2023 | |
RNAC | Cartesian Therapeutics | $0.03 | -$0.07 | $0.04 | 157.14% | $29.94M | $11.68M | $16.80M | 43.79% | 03/02/2023 | |
RNAC | Cartesian Therapeutics | -$0.16 | -$0.01 | -$0.05 | -400.00% | $24.43M | $25.21M | $20.71M | -17.85% | 11/03/2022 | |
RNAC | Cartesian Therapeutics | $0.00 | -$0.09 | $0.06 | 166.67% | $19.66M | — | $39.27M | — | 08/04/2022 | |
RNAC | Cartesian Therapeutics | -$0.22 | -$0.11 | $0.08 | 172.73% | $11.05M | $13.12M | $34.00M | 159.14% | 05/05/2022 | |
RNAC | Cartesian Therapeutics | -$0.14 | -$0.07 | $0.03 | 142.86% | $11.95M | $17.58M | $29.94M | 70.29% | 03/10/2022 | |
RNAC | Cartesian Therapeutics | -$0.09 | -$0.07 | -$0.16 | -128.57% | $4.65M | $12.19M | $24.43M | 100.39% | 11/09/2021 | |
RNAC | Cartesian Therapeutics | -$0.25 | -$0.12 | $0.00 | 100.00% | $0.00 | $6.24M | $19.66M | 215.11% | 08/12/2021 | |
RNAC | Cartesian Therapeutics | -$0.21 | -$0.12 | -$0.22 | -83.33% | $0.00 | $7.52M | $11.05M | 46.94% | 05/13/2021 | |
RNAC | Cartesian Therapeutics | -$0.28 | -$0.12 | -$0.14 | -16.67% | $6.65M | $6.37M | $11.95M | 87.61% | 03/11/2021 | |
RNAC | Cartesian Therapeutics | -$0.26 | — | -$0.09 | — | $0.00 | — | $4.65M | — | 11/05/2020 |
Cartesian Therapeutics (RNAC) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $0.50 | $-0.69 | 172.5 % |
| Q1 | 2025-05-08 | $-0.68 | $-0.61 | -11.5 % |
| Q4 | 2025-03-13 | $-0.40 | $-0.83 | 51.8 % |
| Q3 | 2024-11-07 | $-1.13 | $-0.73 | -54.8 % |
Cartesian Therapeutics (RNAC) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $298.00K | $787.50K | -62.2 % |
| Q1 | 2025-05-08 | $1.10M | $500.00K | 120.0 % |
| Q4 | 2025-03-13 | $-759.00K | $100.00K | -859.0 % |
| Q3 | 2024-11-07 | $387.00K | $2.54M | -84.8 % |
PREGUNTAS FRECUENTES
¿Cuándo Cartesian Therapeutics (NASDAQ:RNAC) publicará los resultados?
Está previsto que Cartesian Therapeutics (RNAC) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Cartesian Therapeutics (NASDAQ:RNAC)?
El BPA real fue de $0.50, que superó la estimación de $-0.69.
¿Cuáles fueron los ingresos de Cartesian Therapeutics (NASDAQ:RNAC)?
Los ingresos reales fueron $298K, que no alcanzó la estimación de $787.5K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.